This policy watch examines the implications of new proposed regulations that would allow Medicare and require Medicaid to cover drugs used to treat obesity, including a relatively new class of highly effective but costly drugs known as GLP-1s.
In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the company recently received through the Sprint for Women’s Health program. The post MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding appeared first on MedCity News.
The Health Resources and Services Administration is making a $52 million investment in 54 health centers to support the health needs of those leaving incarceration. The post HRSA Commits $52M to Health Centers Supporting People Leaving Incarceration appeared first on MedCity News.
Joining Matthew Holt (@boltyboy) on #THCBGang on Tuesday November 26 at 1PM PT 4PM ET are THCB regular writer and ponderer of odd juxtapositions Kim Bellard (@kimbbellard); medical historian Mike Magee (@drmikemagee); and a new guest from Marsh McLennan, Employee Benefits Consultant Ryan Koo (@RyanKoo). You can see the video below & if you’d rather listen…
Facility will initially house approximately 40 principal investigators, alongside 250 graduate students, postdoctoral fellows, computer scientists, and support staff
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The post Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition appeared first on MedCity News.
This brief provides background on gender affirming care and state bans, explains the legal challenge to the Tennessee law, and explores the potential Supreme Court ruling and impact on access across the country.
Pricy GLP-1 medications are here to stay — let’s focus on turning their potential into lasting, meaningful impact. The post The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care appeared first on MedCity News.
The current Affordable Care Act open enrollment season is the first big test of new federal guardrails against fraud. The rules aim to head off unauthorized ACA plan enrollments or switches by rogue agents and entities looking to make money via enrollment commissions. Such sign-ups triggered more than 274,000 consumer complaints through August this year….